Weight | 412.946 g/mol |
---|---|
Formula | C21H21ClN4OS |
Hydrogen Acceptors | 5 |
Hydrogen Donors | 1 |
Aromatic Rings | 3 |
Rotatable Bonds | 4 |
Ziprasidone (146939-27-7)
Score:
#65 in Neuroscience
,
#342 in Biology
,
#360 in Chemistry
"What do you need help with?"
LabBot
- Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder: A 6-Week Placebo-Controlled Trial (Neuropsychopharmacology, 1999)
- Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic (American Journal of Psychiatry, 2006)
- Ziprasidone in the Treatment of Acute Bipolar Mania: A Three-Week, Placebo-Controlled, Double-Blind, Randomized Trial (American Journal of Psychiatry, 2003)
- Ziprasidone treatment of children and adolescents with Tourette's syndrome : A pilot study (Journal of the American Academy of Child and Adolescent Psychiatry, 2000)
- Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. (Journal of Pharmacology and Experimental Therapeutics, 1995)
- Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile (European Journal of Pharmacology, 2001)
-
Including Acute Oral Tox, Skin Sensitization, Eye Irritation, Aquatic Tox, & more. -
SMILESC1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
-
InChIKeyMVWVFYHBGMAFLY-UHFFFAOYSA-N
- Pubchem - Ziprasidone
- Wikipedia - ziprasidone
Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic which is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in people with schizophrenia. Ziprasidone is also used off-label for depression, bipolar maintenance, and post-traumatic stress disorder (PTSD).
Suppliers
Most-cited Publications
Areas of Application
Safety
Alternate Names
Estimated Properties
Boiling Point | 373.88 C | EPA T.E.S.T. |
---|---|---|
Density | 1.39 g/cm3 | EPA T.E.S.T. |
Flash Point | 307.35 C | EPA T.E.S.T. |
Water Solubility | 2.74 mg/L | EPA T.E.S.T. |
External Links
Synthesis
Similar Compounds
Ziprasidone hydrochloride
(122883-93-6)
1 alternate name
3 suppliers
138982-67-9
(138982-67-9)
1 alternate name
3 suppliers
Trifenmorph
(1420-06-0)
1 alternate name
2 safety hazards
3 suppliers
7H-Dibenzo[c,g]carbazole
(194-59-2)
1 alternate name
1 safety hazard
3 suppliers
Ajmalicine
(483-04-5)
1 alternate name
3 suppliers
Centralite
(85-98-3)
1 alternate name
3 suppliers
Asenapine
(65576-45-6)
1 alternate name
3 suppliers
Asenapine
(65576-45-6)
1 alternate name
3 suppliers
Asenapine
(65576-45-6)
1 alternate name
3 suppliers
Asenapine
(65576-45-6)
1 alternate name
3 suppliers
Brilliant Green cation
(18198-35-1)
1 alternate name
3 suppliers
Nordiazepam
(1088-11-5)
1 alternate name
3 suppliers
diclofenac epolamine
(119623-66-4)
1 alternate name
3 suppliers
medazepam
(2898-12-6)
1 alternate name
3 suppliers
BENPERIDOL
(2062-84-2)
1 alternate name
3 suppliers
INDORAMIN
(26844-12-2)
1 alternate name
3 suppliers
Mefenacet
(73250-68-7)
1 alternate name
3 safety hazards
3 suppliers
Diphacinone
(82271-36-1, 82-66-6)
1 alternate name
4 safety hazards
3 suppliers
SARAFLOXACIN HYDROCHLORIDE
(91296-87-6)
1 alternate name
3 suppliers
Fenazaquin
(120928-09-8)
1 alternate name
3 safety hazards
3 suppliers
Trazodone hydrochloride
(19666-36-5, 25332-39-2)
1 alternate name
3 suppliers
Azaperone
(1649-18-9)
1 alternate name
3 suppliers
6-Methyl-1,2-benzanthracene
(2381-16-0)
1 alternate name
3 suppliers
Trifluperidol
(749-13-3)
1 alternate name
3 suppliers
CHLOROPHACINONE
(3691-35-8)
1 alternate name
6 safety hazards
3 suppliers
Fenpyroximate
(111812-58-9)
1 alternate name
3 suppliers
Quinoline Yellow
(8004-92-0, 8003-22-3, 83-08-9)
1 alternate name
3 suppliers
Quinophthalone
(8003-22-3, 83-08-9)
1 alternate name
3 suppliers
CAS Directory